Searched for
TRADE MARGIN CAP
Panel to finalise cancer drugs for 30% trade margin cap; Rs 2,500 crore annual savings possibleAn expert group is finalizing the list of cancer medicines for a new trade margin cap. The government plans to implement a 30% cap to reduc...- SC asks govt to broaden inflated pricing review beyond oncologyThe Supreme Court has asked the government to address high markups on medicines and medical devices. The court questioned the decision to l...
- Two Trades for Today: An IT major for a 5.7% upmove, a mid-cap iron and steel maker’s stock for a rise of almost 6%Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- Asset allocation: Gold leads as equity returns diverge in 2026 so farWelcome to TrendMap, your guide to the performance of different investment segments. In this edition, we present a 10-year performance trac...
- Banks may explore easier forex hedging amid RBI curbsThe Reserve Bank of India has implemented fresh regulations that drastically reduce the maximum limit for dollar forward transactions by co...
- Half of India’s MTF book is in smallcaps; Nithin Kamath flags liquidity risksZerodha founder Nithin Kamath warned that small and microcap stocks account for a substantial share of India’s margin trading facility book...
- Apollo, Max Health, other hospital stocks rally up to 5% despite cancer drug price caps. Why Jefferies stays bullishHospital stocks rose up to 5% after the government capped trade margins on non-scheduled anti-cancer drugs at 30%, potentially reducing med...
- Cancer drugs may get up to 70% cheaper as govt fixes trade margins on non-scheduled medicines at 30%The government is aiming to cap trade margins on anti-cancer medications at 30%. An expert committee has been tasked with compiling a repor...
- Form panel to curb pharma freebies: SCThe Supreme Court has ordered the government to establish a committee to investigate unethical pharmaceutical marketing. The committee is t...
- Two Trades for Today: A commodities exchange for a 5.95% upmove, a mid-cap financial service stock for a rise of about 6%Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- National Medical Commission bans doctors & hospitals from using AI-generated patient testimonials, fake cure claims in medical adsThe National Medical Commission has implemented new ethical advertising guidelines affecting doctors and hospitals. These guidelines prohib...
- Govt set to cap trade margins on more cancer drugs before SC hearingThe Indian government plans to announce a new list of cancer drugs for trade margin rationalisation today. Union Health Minister JP Nadda w...
- ETMarkets Smart Talk| Rising US yields could hit expensive mid, smallcaps harder: Harish KrishnanIn an interaction with Kshitij Anand of ETMarkets, Harish Krishnan, CIO – Equity, Aditya Birla Sun Life AMC, discusses the risks and opport...
- Chinese independent refiners turn to Iraq, Qatar as Iranian crude supplies dwindleChinese independent refiners have turned to buying Iraqi and Qatari crude as Iranian supplies dwindle. The traders report purchases totalin...
- Jefferies favours Indian largecap stocks amid rising bond yieldsJefferies has suggested enhancing investments in large-cap stocks in India, citing their favorable valuations compared to midcaps. The brok...
- ElevenLabs bets big on India; GCC jobs shiftElevenLabs is planning to expand its voice AI platform to include all 22 Indian languages. This and more in today’s ETtech Top 5.
- IRDAI’s insurance distribution paper: Economics in focus, consumer protection gaps remainRules and caps can change behaviour. Incentives determine whether organisations merely comply with the rules or actually change the behavio...
- Indian IT’s Q2 earnings dilemma deepens: More deals but weaker growth and falling pricing powerAs Indian IT firms gear up for their Q2 earnings report, the landscape appears mixed. Strong deal activity persists, yet clients are pushin...
- Fortis, Apollo, other hospital stocks slump up to 10% in 2 days after SC questions steep markups. Buying opportunity?Hospital stocks extended losses for a second session after the Supreme Court questioned steep markups on cancer drugs and raised concerns o...
- Jefferies picks 6 hospitals as Buy after steep correction offers 'excellent' entry points. Check target priceJefferies has maintained a Buy rating on six hospital stocks, including Apollo Hospitals and Fortis Healthcare, following a sharp correctio...
Load More
